Amagasaki-city, Japan Clinical Trials

A listing of Amagasaki-city, Japan clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 54 clinical trials
Observational Study of Patients With Moderate to Severe Chronic Plaque Psoriasis

This study will assess the use of risankizumab in adult patients with moderate to severe chronic plaque psoriasis and compare risankizumab to other commonly used biologics.

Nippon Life Saiseikai Public Interest Foundation Nippon Life Hospital /ID# 224743
 (5.7 away) Contact site
  • 93 views
  • 28 Jun, 2021
  • +344 other locations
The Bleeding With Antithrombotic Therapy Study 2

The purpose of this study is to determine the incidence and severity of bleeding complications in patients with cerebrovascular and cardiovascular diseases treated with oral antithrombotic therapy.

National Cerebral and Cardiovascular Center
 (8.6 away) Contact site
  • 51 views
  • 22 Jan, 2021
  • +6 other locations
Intra-operative Pancreatoscopy in Patients With IPMN

To demonstrate the added value of intraoperative pancreatoscopy in patients undergoing partial pancreatic resection for the treatment of Intraductal Papillary Mucinous Neoplasm (IPMN) as it pertains to detection of discontinuous (skip) lesions in the remnant pancreas; to generate a hypothesis for a subsequent randomized control trial.

Kansai Medical University
 (6.1 away) Contact site
  • 6 views
  • 21 Jul, 2021
  • +9 other locations
Special Drug Use Surveillance for Entresto Tablets

This is a single arm, multicenter, observational study in Japanese chronic heart failure patients.

Novartis Investigative Site
 (3.0 away) Contact site
  • 0 views
  • 01 Aug, 2021
  • +80 other locations
Calquence CLL rr Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - All Patient Investigation

To understand the incidence of ADRs of Calquence 100 mg capsules (acalabrutinib) used in patients with relapsed or refractory chronic lymphocytic leukaemia (including small lymphocytic lymphoma) in a real-world post-marketing setting.

Research Site
 (6.1 away) Contact site
  • 0 views
  • 20 Jul, 2021
  • +17 other locations
A Study to Evaluate the Safety of DAYVIGO (Lemborexant) Tablets in Participants With Insomnia.

The purpose of the study is to evaluate the incidence of somnolence, parasomnia, narcoleptic symptoms, and suicidal ideation/suicidal behavior after administration of lemborexant (DAYVIGO) in daily practice.

Eisai trial site 10
 (6.1 away) Contact site
  • 0 views
  • 01 Aug, 2021
  • +38 other locations
Study of Longitudinal Observation for Patient With X-linked Hypophosphatemic Rickets/Osteomalacia in Collaboration With Asian Partners

Through observation of patients with X-linked hypophosphatemic rickets/osteomalacia (XLH) for up to 5 years, the study intends to collect data that allow achievement of the following objectives To determine medical characteristics of the disease and the disease process To determine physical and psychological burden on patients as well as economic …

Osaka University Hospital
 (6.1 away) Contact site
  • 0 views
  • 15 Feb, 2021
  • 1 location
ISTODAX for Intravenous Infusion Drug Use Results Survey- Relapsed or Refractory Peripheral T-Cell Lymphoma

To ascertain the safety and efficacy of Istodax in actual clinical settings in patients with relapsed or refractory peripheral T-cell lymphoma (PTCL) who receive Istodax. Planned registration period 4 years Planned surveillance period 5 years and 6 months

t-cell lymphoma
refractory peripheral t-cell lymphoma
Nihon Seimei Hospital
 (5.7 away) Contact site
  • 0 views
  • 10 Jun, 2021
  • 1 location
Specified Drug-use Survey on Abilify Prolonged Release Aqueous Suspension for IM Injection (Prevention of Relapse of Mood Episodes in BP)

To investigate the safety for an observation period of 52 weeks with use of Abilify prolonged release aqueous suspension for intramuscular (IM) injection in patients with bipolar I disorder for prevention of recurrence/relapse of mood episodes in the routine clinical setting. The early stage safety after the switching from oral …

Pharmacovigilance Department
 (6.9 away) Contact site
  • 0 views
  • 12 May, 2021
  • 1 location
Samsca Post-marketing General Drug Use-results Survey in Patients With Hyponatremia in SIADH

The purpose of this study is to confirm the safety of tolvaptan in patients with hyponatremia in syndrome of inappropriate antidiuretic hormone secretion (SIADH) in Japan

Pharmacovigilance Department
 (6.9 away) Contact site
  • 0 views
  • 08 Apr, 2021
  • 1 location